Chemotherapy in Pregnancy: Assessing the Safety of Adriamycin Administration in Pregnancy Complicated by Breast Cancer
- Priyanshu Nain,
- Lakshya Seth,
- Ashley Shawn Bell,
- Priyanka Raval,
- ,
- Augusta University,
- ,
- ,
- Inova Fairfax Medical Campus
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Pregnancy-associated breast cancer is challenging to treat. Treatment with chemotherapeutic agents such as anthracyclines poses a risk of cardiotoxicity, despite being considered safe after the second trimester of pregnancy. Management requires multidisciplinary comanagement with cardio-obstetrics, cardiology-oncology, maternal-fetal medicine, and oncology.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Article number
102141Journal (Volume, Issue Number)
JACC: Case Reports (Volume 28)Publication milestones
- Published - 12/20/2023
Publication status
Published - 12/20/2023
Publication IDs
- Scopus: 85180102865
- ORCID: /0000-0003-0253-1174/work/172679176
Publication metrics
Metrics
Fractional count
4
Fractional count
0.50
Fractional count
4
Fractional count
0.50
Fractional count
4
Fractional count
1
PlumX, opens in new tab
Citation count
2
Captures
11
